Target intelligence / Profile preview

Extracellular matrix structural components in shoulder tissues (Shoulder ECM)

Target
Shoulder ECM
Molecular classification
Structural protein, Other
01

Overview

Extracellular matrix (ECM) structural components in shoulder tissues represent a complex assembly of macromolecules, including Type I and Type III collagens, proteoglycans (such as decorin and biglycan), and glycoproteins (such as tenascin-C and fibronectin), which provide the mechanical framework for tendons, ligaments, and the joint capsule (Riley, 2004, PubMed ID: 15240115). These components are vital for maintaining the tensile strength and elasticity required for the wide range of motion of the glenohumeral joint, while also serving as a scaffold for cell signaling and mechanotransduction (Maffulli et al., 2000, PubMed ID: 11032111). In pathological states like rotator cuff tears or adhesive capsulitis (frozen shoulder), the ECM undergoes significant remodeling characterized by altered collagen ratios and increased expression of degradative enzymes like matrix metalloproteinases (Voloshin et al., 2005, PubMed ID: 15814444). While specific components like collagen can be targeted by enzymatic therapies (e.g., collagenase clostridium histolyticum) to treat capsular fibrosis, the 'shoulder ECM' as a whole is considered a broad tissue category rather than a discrete, singular therapeutic target (Lewis et al., 2009, PubMed ID: 19345130).

Other names
Shoulder extracellular matrixRotator cuff matrixGlenohumeral joint connective tissueShoulder capsule matrix
02

Mechanism of action

Enzymatic degradation of collagen fibers to reduce tissue stiffness and improve range of motion.

03

Biological functions

Structural supportCell adhesionTissue integrityOther
04

Disease associations

InflammationOther
05

Safety considerations

Tendon ruptureSystemic connective tissue disruptionImpaired wound healingHypersensitivity reactions
06

Interacting drugs

Collagenase clostridium histolyticum
07

Biomarkers

Collagen type IIIMatrix metalloproteinase-1 (MMP-1)Tenascin-CC-terminal telopeptide of type II collagen (CTX-II)

Beyond the preview

Go deeper on Extracellular matrix structural components in shoulder tissues (Shoulder ECM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix structural components in shoulder tissues (Shoulder ECM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call